These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38478096)

  • 1. Role of HCN channels in the functions of basal ganglia and Parkinson's disease.
    Qi ZX; Yan Q; Fan XJ; Peng JY; Zhu HX; Jiang YM; Chen L; Zhuang QX
    Cell Mol Life Sci; 2024 Mar; 81(1):135. PubMed ID: 38478096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantia nigra control of basal ganglia nuclei.
    Guatteo E; Cucchiaroni ML; Mercuri NB
    J Neural Transm Suppl; 2009; (73):91-101. PubMed ID: 20411770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of hyperpolarization-activated, cyclic nucleotide-gated cation channels in dorsal root ganglion in neuropathic pain.
    Wan Y
    Sheng Li Xue Bao; 2008 Oct; 60(5):579-80. PubMed ID: 18958363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous HCN Channels Modulate the Firing Activity of Globus Pallidus Neurons in Parkinsonian Animals.
    Hao XM; Xu R; Chen AQ; Sun FJ; Wang Y; Liu HX; Chen H; Xue Y; Chen L
    Front Aging Neurosci; 2019; 11():190. PubMed ID: 31402860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active decorrelation in the basal ganglia.
    Wilson CJ
    Neuroscience; 2013 Oct; 250():467-82. PubMed ID: 23892007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels regulate firing of globus pallidus neurons in vivo.
    Chen L; Xu R; Sun FJ; Xue Y; Hao XM; Liu HX; Wang H; Chen XY; Liu ZR; Deng WS; Han XH; Xie JX; Yung WH
    Mol Cell Neurosci; 2015 Sep; 68():46-55. PubMed ID: 25858108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
    Milosevic L; Gramer R; Kim TH; Algarni M; Fasano A; Kalia SK; Hodaie M; Lozano AM; Popovic MR; Hutchison WD
    Neurobiol Dis; 2019 Apr; 124():46-56. PubMed ID: 30391540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Roles of Microglia in the Basal Ganglia in Parkinson's Disease.
    Choudhury ME; Kigami Y; Tanaka J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurophysiology of HCN channels: from cellular functions to multiple regulations.
    He C; Chen F; Li B; Hu Z
    Prog Neurobiol; 2014 Jan; 112():1-23. PubMed ID: 24184323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: An Emerging Role in Neurodegenerative Diseases.
    Chang X; Wang J; Jiang H; Shi L; Xie J
    Front Mol Neurosci; 2019; 12():141. PubMed ID: 31231190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal ganglia control of substantia nigra dopaminergic neurons.
    Lee CR; Tepper JM
    J Neural Transm Suppl; 2009; (73):71-90. PubMed ID: 20411769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCN2 and HCN1 channels govern the regularity of autonomous pacemaking and synaptic resetting in globus pallidus neurons.
    Chan CS; Shigemoto R; Mercer JN; Surmeier DJ
    J Neurosci; 2004 Nov; 24(44):9921-32. PubMed ID: 15525777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.
    Jesse S; Kassubek J; Müller HP; Ludolph AC; Unrath A
    BMC Neurol; 2012 Dec; 12():163. PubMed ID: 23273141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional changes of the basal ganglia circuitry in Parkinson's disease.
    Blandini F; Nappi G; Tassorelli C; Martignoni E
    Prog Neurobiol; 2000 Sep; 62(1):63-88. PubMed ID: 10821982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
    Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
    Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease.
    Marsden CD; Obeso JA
    Brain; 1994 Aug; 117 ( Pt 4)():877-97. PubMed ID: 7922472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
    Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
    Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 dopamine receptors modulate neuronal resonance in subthalamic nucleus and cortical high-voltage spindles through HCN channels.
    Yang C; Yan Z; Zhao B; Wang J; Gao G; Zhu J; Wang W
    Neuropharmacology; 2016 Jun; 105():258-269. PubMed ID: 26808313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
    Delaville C; Navailles S; Benazzouz A
    Neuroscience; 2012 Jan; 202():424-33. PubMed ID: 22138505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.